Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)

NCT06990204 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Azilsartan medoxomil 80 mg tablet
DRUG: Edarbi® 80 mg tablets

Sponsor

Gedeon Richter Plc.